Cargando…
A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol
The development of radiation countermeasures for acute radiation syndrome (ARS) has been underway for the past six decades, leading to the identification of multiple classes of radiation countermeasures. However, to date, only two growth factors (Neupogen and Neulasta) have been approved by the Unit...
Autores principales: | Cheema, Amrita K., Mehta, Khyati Y., Fatanmi, Oluseyi O., Wise, Stephen Y., Hinzman, Charles P., Wolff, Josh, Singh, Vijay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796029/ https://www.ncbi.nlm.nih.gov/pubmed/29283379 http://dx.doi.org/10.3390/ijms19010079 |
Ejemplares similares
-
Comparative proteomic analysis of serum from nonhuman primates administered BIO 300: a promising radiation countermeasure
por: Girgis, Michael, et al.
Publicado: (2020) -
Plasma Derived Exosomal Biomarkers of Exposure to Ionizing Radiation in Nonhuman Primates
por: Cheema, Amrita K., et al.
Publicado: (2018) -
Metabolomic Studies of Tissue Injury in Nonhuman Primates Exposed to Gamma-Radiation
por: Cheema, Amrita K., et al.
Publicado: (2019) -
Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure
por: Li, Yaoxiang, et al.
Publicado: (2021) -
Analysis of
the Proteomic Profile in Serum of Irradiated
Nonhuman Primates Treated with Ex-Rad, a Radiation Medical Countermeasure
por: Carpenter, Alana D., et al.
Publicado: (2023)